LAZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
LAZ is not a strong buy right now for a beginner long-term investor with $50,000-$100,000 and an impatient need to enter now. The stock has mixed-to-bearish technicals, no proprietary buy signal, and analyst sentiment is split with multiple price target cuts and more cautious ratings than bullish ones. I would not buy aggressively at this price; the better call is to hold and wait for a clearer bullish trend or better earnings confirmation.
LAZ is in a weak/neutral technical posture. MACD histogram is negative and still contracting, RSI_6 at 45.17 is neutral with no momentum edge, and moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which signals the longer-term trend is still under pressure. Price at 41.54 is just below pivot 41.829, with nearby support at 39.636 and resistance at 44.021. The stock has some short-term upside probability based on pattern history, but the current setup does not show a clean buy trend.
["Upcoming Q2 and H1 2026 earnings release on 2026-07-23 could act as a catalyst.", "Asset management business has shown healthy AUM growth in prior commentary, supporting a longer-term earnings base.", "If M&A activity improves in 2026-2027, Lazard's advisory segment could benefit.", "Options positioning is call-skewed, indicating some bullish sentiment."]
["Goldman Sachs lowered the price target to $40 and keeps a Sell rating.", "UBS lowered its target to $44 and keeps Neutral.", "Morgan Stanley keeps Underweight despite raising target.", "Recent commentary highlighted weaker-than-expected financial advisory activity due to delayed deal closures.", "Technical trend remains bearish with moving averages stacked negatively.", "No AI Stock Picker or SwingMax buy signal is present.", "Hedge funds and insiders show no significant positive trading trend.", "No recent congress trading data was available."]
No usable latest-quarter financial snapshot was provided due to a data error, so there is no confirmed quarter-by-quarter revenue or EPS update to analyze. The only fundamental clues in the dataset suggest mixed operating trends: weaker advisory activity from delayed deal closures, but a 15% rise in assets under management in the asset management segment. The latest visible season context is the upcoming Q2 and H1 2026 results on 2026-07-23, which will be the next major fundamental checkpoint.
Analyst sentiment is mixed but leaning cautious. Recent cuts include Goldman Sachs to $40 with a Sell rating and UBS to $44 with a Neutral rating. Bulls are present but less convincing: Argus kept Buy while cutting target to $52, and BofA kept Buy with a target cut to $63. Overall, Wall Street pros see some medium-term upside if M&A activity improves, but current consensus is still held back by weak advisory execution and several underweight/sell views.
